Literature DB >> 479158

Carbohydrate of the human plasminogen variants. III. Structure of the O-glycosidically linked oligosaccharide unit.

M L Hayes, F J Castellino.   

Abstract

The preceding two manuscripts in this issue (Hayes, M. L., and Castellino, F. J. (1979) J. Biol. Chem. 254, 8768-8771, 8772-8776) describe the isolation and characterization of glycopeptides from human plasminogen affinity chromatography variants 1 and 2. Plasminogen variant 1 contains an asparagine288-based branched carbohydrate structure, which has been established in the immediately preceding manuscript. This structure is absent in variant 2. Plasminogen variants 1 and 2 contain a threonine-based glycoconjugate. This latter structure has been established by combination of methylation data, glycosidase digestions, periodate oxidations, and Smith degradations of the beta-eliminated reduced oligosaccharides. One glycopeptide unit, isolated from both plasminogen variants 1 (1D) and 2 (2D) possessed the following structure: Sia alpha 2 yields 3Gal beta 1 yields 3GalNAc-Thr. The threonine was found to be residue 345 in the Glu-plasminogen sequence. Another glycopeptide unit was also found to be present, in lower yields in both variants 1 (1E) and 2 (2E). The structure of this unit was: Sia alpha 2 yields 3Gal beta1 yields 3GalNAc-Thr. : formula: (see text), alpha 2,6 Sia. Again Thr 345 was the glycosylated amino acid. The amino acid sequence around the glycosylated threonine was found to be NH2-Ala.Pro.Thr(CHO).Ala.Pro.Pro.Glu.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 479158

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  Amino acid distributions around O-linked glycosylation sites.

Authors:  I B Wilson; Y Gavel; G von Heijne
Journal:  Biochem J       Date:  1991-04-15       Impact factor: 3.857

2.  Effect of desialylation on the biological properties of human plasminogen.

Authors:  M S Stack; S V Pizzo; M Gonzalez-Gronow
Journal:  Biochem J       Date:  1992-05-15       Impact factor: 3.857

3.  Neonatal plasminogen displays altered cell surface binding and activation kinetics. Correlation with increased glycosylation of the protein.

Authors:  J M Edelberg; J J Enghild; S V Pizzo; M Gonzalez-Gronow
Journal:  J Clin Invest       Date:  1990-07       Impact factor: 14.808

Review 4.  The plasmin-antiplasmin system: structural and functional aspects.

Authors:  Johann Schaller; Simon S Gerber
Journal:  Cell Mol Life Sci       Date:  2010-12-07       Impact factor: 9.261

Review 5.  New insights into the role of Plg-RKT in macrophage recruitment.

Authors:  Lindsey A Miles; Shahrzad Lighvani; Nagyung Baik; Caitlin M Parmer; Sophia Khaldoyanidi; Barbara M Mueller; Robert J Parmer
Journal:  Int Rev Cell Mol Biol       Date:  2014       Impact factor: 6.813

6.  The influence of the nature of the asparagine 289-linked oligosaccharide on the activation by urokinase and lysine binding properties of natural and recombinant human plasminogens.

Authors:  D J Davidson; F J Castellino
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

7.  Effect of tunicamycin on appearance of carbohydrate variants of plasminogen in rat and rabbit plasma.

Authors:  J R Powell; R K Bretthauer; F J Castellino
Journal:  Proc Natl Acad Sci U S A       Date:  1981-11       Impact factor: 11.205

8.  Differential effects of 1-deoxynojirimycin on the intracellular transport of secretory glycoproteins of human hepatoma cells in culture.

Authors:  J B Parent; T K Yeo; K T Yeo; K Olden
Journal:  Mol Cell Biochem       Date:  1986 Nov-Dec       Impact factor: 3.396

Review 9.  Bacterial plasminogen receptors: mediators of a multifaceted relationship.

Authors:  Martina L Sanderson-Smith; David M P De Oliveira; Marie Ranson; Jason D McArthur
Journal:  J Biomed Biotechnol       Date:  2012-10-14

10.  Three are better than one: plasminogen receptors as cancer theranostic targets.

Authors:  Patrizia Ceruti; Moitza Principe; Michela Capello; Paola Cappello; Francesco Novelli
Journal:  Exp Hematol Oncol       Date:  2013-04-17
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.